Ardoz Healthcare International develops and produces cosmetic and medical device products based on the unique Ardox-X® active oxygen technology. Ardoz is the inventor of this stabilized complex, which enables the controlled release of active oxygen in a safe manner.
Unlike traditional oxygen donors, Ardox-X® releases oxygen without generating harmful free radicals, supporting antimicrobial action, and long-term safety. This makes the technology suitable for applications in oral care, skin care and medical treatments.
Our Ardox-X® technology is designed to release active oxygen under specific conditions such as contact with saliva, enzymes or the skin environment. This controlled activation ensures targeted oxygen delivery where it is needed most.
The non-radical nature of the released oxygen prevents damage to cells and DNA, while maintaining strong antimicrobial and healing properties.
Our Ardox-X® active oxygen technology is used in multiple oral care applications, including the treatment of periodontitis, peri-implantitis, gingivitis and halitosis. It penetrates biofilm, reduces harmful bacteria and supports tissue healing.
Our Ardox-X® active oxygen technology is used in dermatological applications. It treats red, itchy and scaly skin or scalp that is caused by psoriasis and dermatitis (eczema).
Our Ardox-X® technology is supported by various scientific studies and clinical evaluations, demonstrating its effectiveness in reducing biofilm, improving oral health.
Founded in 2002, Ardoz combines scientific research with product development and has its own R&D laboratory for technology research and analytical measurements. Through continuous research and international partnerships, Ardoz develops cosmetic and medical device products for oral care and skin care based on our active oxygen technology.
